Internal Medicine, Nephrology · Erie, PA
NPI
1306873914
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
350 E Bayfront Pkwy, Unit C
Erie, PA, 16507
Phone (814) 455-2279
Groups this clinician bills Medicare through
Medicare paid, 2024
$147K
1,766 services
Medicare patients, 2024
451
Average age 74
Drug cost, 2024
$2.5M
3,162 prescriptions
Company payments, 2025
$494
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Asim R Singh was code 99232 (hospital e&m - subsequent), 757 times for 158 patients. In total Asim R Singh billed 1,766 services in 15 codes, and Medicare paid $147K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 757 | 158 | $63.17 | $48K |
| 99214 Office E&M - Established | Office | 216 | 192 | $66.35 | $14K |
| 99233 Hospital E&M - Subsequent | Facility | 213 | 58 | $93.38 | $20K |
| 99223 Hospital E&M - Initial | Facility | 168 | 135 | $138.11 | $23K |
| 90935 Hemodialysis | Facility | 159 | 67 | $56.86 | $9,041 |
| 90966 ESRD Related Services (not dialysis) | Office | 63 | 19 | $224.35 | $14K |
| 90945 Peritoneal Dialysis | Facility | 53 | 21 | $68.46 | $3,628 |
| 99222 Hospital E&M - Initial | Facility | 46 | 43 | $104.89 | $4,825 |
| 99205 Office E&M - New | Office | 39 | 39 | $169.21 | $6,599 |
| 99221 Hospital E&M - Initial | Facility | 26 | 24 | $66.39 | $1,726 |
By year: 2022 $182K for 2,329 services; 2023 $142K for 1,746 services; 2024 $147K for 1,766 services.
Medicare prescription drug claims, 2024
In 2024, the drug Asim R Singh prescribed most often to Medicare patients was Carvedilol, with 417 prescriptions and refills. In total Asim R Singh wrote 3,162 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carvedilol Generic | 417 | 910 | 118 | $2,781 |
| Hydralazine Hcl Generic | 298 | 634 | 82 | $4,086 |
| Labetalol Hcl Generic | 165 | 327 | 42 | $4,086 |
| Amlodipine Besylate Generic | 134 | 312 | 41 | $465 |
| Furosemide Generic | 131 | 271 | 37 | $466 |
| Lisinopril Generic | 100 | 231 | 30 | $444 |
| Bumetanide Generic | 96 | 227 | 31 | $4,074 |
| Losartan Potassium Generic | 94 | 247 | 25 | $677 |
| Sodium Chloride 0.9 % Sodium Chloride | 78 | 78 | Under 11 | $1,411 |
| Jardiance Empagliflozin | 77 | 154 | 20 | $88K |
| Hydrochlorothiazide Generic | 76 | 218 | 25 | $189 |
| Metoprolol Succinate Generic | 65 | 152 | 18 | $911 |
| Calcitriol Generic | 63 | 154 | 19 | $1,293 |
| Potassium Chloride Generic | 61 | 137 | 18 | $1,136 |
| Olmesartan Medoxomil Generic | 61 | 167 | 20 | $1,572 |
Brand drugs: 489 claims; generic drugs: 2,673 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Asim R Singh $494 ($494 in general payments such as food, travel and fees) from 13 companies. The largest payer was Novo Nordisk Inc with $125.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $125 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $120 |
| Ardelyx, Inc. ARDX | 2 | $41.64 |
| Calliditas Therapeutics US Inc. | 1 | $32.3 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $29.83 |
| Akebia Therapeutics Inc AKBA | 1 | $26.35 |
| Recor Medical Inc | 1 | $22.93 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $21.27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20.93 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $17.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.